UK Police Chiefs Call for Blocking Unsafe Social Media for Under16s Potential Regulatory Pressure on Tech Giants Nicki Minajs Praise of Elon Musk at SpaceX Starbase Event Highlights Celebrity Endorsement Amid Starship V3 Delay Chinas New Blueprint May Reshape Global Electric Vehicle and AI Standards Broadening Inflation Pressures Beyond Energy and Geopolitical Shocks Pfizer Wins Singapore Trademark Dispute with Merck Over Vaccine Brand Market Rally Highlights Diverging Stock Performance Over SixWeek Record Run Vyome Holdings Inc HIND Q4 2025 Earnings Significant EPS Beat Highlights Cost Discipline ALRM Q1 2026 Earnings EPS Beats Estimates by 54 Stock Edges Higher CRS Q1 2026 Earnings EPS Beats Estimates by 408 Stock Shows Modest Uptick CCB Q1 2026 Earnings EPS Falls Short as Profitability Pressures Mount Ultragenyx Q1 2026 Earnings WiderThanExpected Loss as No Revenue Reported German American Bancorp Inc Q1 2026 Earnings EPS Misses Expectations Amid Muted Stock Reaction Virtus Global MultiSector Income Fund VGI Edges Higher Amid Balanced Trading Peakstone Realty Trust PKST Holds Steady Near Support Amid Low Volatility Crocs Inc CROX Holds Steady Near Midpoint as Footwear Sector Watches for Breakout Horizon Technology Finance HRZN Sees Modest Uptick Holds Above Key Support FrontView REIT Inc FVR Slides 15 as Sector Headwinds Weigh on Momentum SGLY Q3 2019 Earnings EPS Misses Estimates Sharply Amidst Continued Operational Headwinds GSK Q1 2026 Earnings EPS Surpasses Expectations Amid Solid Operational Performance Littelfuse LFUS Q1 2026 Earnings Earnings Beat Driven by Operational Discipline and Demand Resilience Triumph Financial TFIN Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response DCTH Q1 2026 Earnings Narrowed Loss Beats Estimates Amid Continued Commercial Progress Accuray ARAY Q1 2026 Earnings EPS Misses Estimates as Revenue Figures Remain Unreported UK Exports to US Plunge by 25 Following Trumps Liberation Day Tariff Blitz FHTX Q1 2026 Earnings NarrowerThanExpected Loss Amid Continued Pipeline Progress ADMA Biologics Slides 109 Key Support Levels in Focus Amid Biotech Headwinds